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ABSTRACT 
 
Emission of volatile organic substances (VOC) from articles inside a car may lead to adverse 
health effects in exposed drivers. Presently, no general concept to derive maximum exposure 
levels inside cars has been published. Therefore, we recommend techniques for three types of 
maximum exposure levels inside cars, namely for (i) chronic exposure to non-genotoxic 
substances (ELIA, chronic), (ii) short term exposure inside automotive vehicles (STELIA) 
and (iii) genotoxic substances acting by threshold mechanisms (ELIA, cm). For derivation of 
the ELIA, chronic, we recommend to start with a Lowest Observed Adverse Effect Level 
(LOEL) or a Benchmark Dose 10 (BMD10) and use a procedure including four steps: a. 
estimation of the No Observed Effect Level (NOEL), b. extrapolation from laboratory animal 
to man, c. extrapolation to the general population due to interindividual differences and d. 
extrapolation to continuous exposure. To derive STELIAs a three-step-procedure is 
recommended, starting with a LOEL and a. estimating the NOEL, b. extrapolating from 
animal to man and c. extrapolating to the general population. Derivation of ELIA, cm, the 
maximum exposure level for carcinogens acting by a threshold mechanism, is certainly the 
most problematic procedure. We recommend to start with the lower 95% confidence limit for 
the most sensitive tumor type known in animals (BMD05) and a. extrapolate from animal to 
man and b. use a safety factor of 1/50 000 unless specific research succeeded in 
demonstrating specific levels of thresholds. It must be considered that a general concept for 
maximum exposure levels can not replace an intelligent toxicological approach considering 
the mechanism of action of individual substances. However, the strategy suggested here offers 
a practical technique for identification of individual problematic exposures that require an 
intensive toxicological evaluation. 
 
Keywords: Indoor air, emissions, exposure limits in cars, automotive vehicles, safety factors 
 
 
INTRODUCTION 
 
Indoor Air qualitity is of increasing interest 
for manufacturers, consumers and regulators. 
Catchphrases like Sick Building Syndrom or 
Building Related Illness draw a link between 
adverse health effects of residents to the 
quality of indoor air (Wiesmueller, 1997). 
One parameter between others that has an 
impact on indoor air quality is the emission 
of volatile organic substances from articles 
used in the indoor environment. The issue 
was picked up by regulators, and the 
Construction Products Directive of the 
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European Union (directive 93/68/EC) 
requires that construction products must not 
affect the health of residents.  
 
If epidemiological and/or toxicological data 
for individual substances are available, they 
most likely represent workplace conditions. 
The deviation of Workplace Exposure Limits 
is well established. However, in indoor 
environments not only healthy workers are 
exposed, but also old and young people, 
children and sick people. The indoor air 
hygiene commission of the German 
Environmental Protection Agency 
(“Umweltbundesamt”, UBA) published a 
scheme to derive Target Recommended 
Maximum Exposure Levels for indoor air 
(Innenraumlufthygienekommission des 
Umweltbundesamtes 1996). Safety-factors 
applied on NOAELs for individual 
compounds are applied to pay attention to 
extended exposure times and a more 
sensitive population. By this way, 
recommended Maximum Exposure Levels 
(“Richtwerte”, RW) are derived which are 
applicable for indoor air in buildings.  
 
The indoor air quality in cars also attracted 
the attention of scientists. For instance 
increased levels of DNA single strand breaks 
have been observed in mononuclear blood 
cells of taxi drivers (Oesch et al., 1994).  
Nearly all car manufacturers have individual 
lists or mutual lists of restricted substances. 
The aim of such lists is to avoid allegations 
due to smell and toxic effects caused by 
emissions from articles used inside the car. In 
the present article, we present a technique to 
derive Maximum Exposure Levels inside a 
car for chronic and short term exposures.  
 
PROPOSAL FOR THE DERIVATION 
OF EXPOSURE LIMITS IN AUTO-
MOTIVE VEHICLES 
 
In many instances driving a car is a 
workplace, e. g. for taxi-, bus- and lorry-
drivers. In this respect, occupational 
exposure limits and maximum exposure 
limits applicable for workplaces may be used 
without any modification. However, at a 
workplace it is usually known what 
substances are handled and, therefore, which 
exposure limits have to be checked. This is 
different in a car, and it is prudent to check 
articles used inside the car in climate 
chambers in advance. Further, also children, 
elderly and sick people travel by car, so the 
higher sensitivity of the potentially exposed 
population has to be taken into account. It is 
to be expected that these sensitive individuals 
spend less than 40 hours per week in a car, as 
is the case for professional drivers. 
Nevertheless, an exposure-time adjustment 
seems to be justified as in some countries 
people spend more than 90 % of time in 
confined spaces, i.e. in flats and cars. Thus, 
there is no reason why people sitting in cars 
should be exposed to higher VOC 
concentrations compared to indoor air in 
buildings.  
 
EXPOSURE LEVEL INSIDE AUTO-
MOTIVE VEHICLES (ELIA, CHRONIC) 
 
To derive an Exposure Level Inside 
Automotive Vehicles (ELIA) for chronic 
exposure we recommend a procedure 
including four steps (a-d in Figure 1).  
 
a. From LOEL to NOEL or BMD10
The first step in the recommended procedure 
is derivation of the NOAEL or a benchmark 
dose 10 (BMD10) (Crump, 1984) for non-
genotoxic effects. Kalberlah et al. issued a 
report which provides guidance how and 
when the benchmark dose concept shall be 
used instead of the NOAEL (Kalberlah, 
2003).  For the next steps, the recommend-
dations from ECETOC should be applied 
(ECETOC, 2003). The NOAEL may be 
estimated by dividing the LOAEL by a factor 
of three. The factor for the extrapolation 
from a LOAEL to a NOAEL depends on the 
quality of effects seen at the LOAEL and on 
the steepness of the dose-response curve. 
Lower or higher factors than three may be 
justified. If no data for chronic exposure are 
available, a divisor of six for sub acute data 
and a divisor of two for sub chronic data are 
used to estimate the NOAEL (chronic). For 
exclusively local effects below the level of 
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exposures causing systemic cytotoxicity, a 
duration extrapolation is not seen as 
necessary (ECETOC, 2003).  
 
Fig. 1: Strategy to derive an Exposure level Inside Automotive Vehicles (ELIA, chronic)  
including four steps: a. estimation of the No Observed Effect Level (NOEL) from the Lowest 
Observed Adverse Effect Level (LOAEL), b. extrapolation from laboratory animal to man, c. 
extrapolation to the general population due to interindividual differences, d. extrapolation to 
continuous exposure with 168 h per week. 
 
 
b. Interspecies extrapolation 
Interspecies extrapolation can be done by 
scaling factors. A factor of seven for mouse 
to man, four for rat to man, two for monkey 
to man and two for dog to man has been 
recommended (ECETOC, 2003). Known 
differences in the metabolism may allow to 
modify these scaling factors. For local effects 
of water-soluble gases an extrapolation from 
animal to man is not necessary. The scaling 
factor may be adjusted if required by known 
differences concerning metabolism and 
toxicokinetics between animal and man. If 
there is reason for concern that an 
extrapolation by scaling might underestimate 
the risk for man, a default value of 10 may be 
used, as is done in the RW-concept of the 
German UBA (Innenraumlufthygiene-
kommission des Umweltbundesamtes, 1996). 
 
c. Interindividual differences 
An intra species extrapolation-factor of five  
can be considered to be sufficient for the 
general population (ECETOC, 2003). The 
need for an additional factor for children is 
questionable if the substance is unlikely to 
affect the developing foetus. If there is 
reason for concern that children are not 
sufficiently covered, an additional factor of 2 
may be introduced as is done in the RW-
concept of the German UBA 
(Innenraumlufthygienekommission des 
Umweltbundesamtes, 1996).  
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d. Extrapolation to continuous exposure 
As people in indoor environments may be 
exposed 168 h per week instead of only 40 h, 
a factor of 5 should be applied for the 
correction of exposure time for systemic 
effects. This factor might not be necessary 
for substances with a short half-life-time at 
concentrations below the NOAEL. Of main 
interest are effects provoked by inhalative 
exposure. Route to route extrapolation is 
strictly only feasible for systemic effects and 
provided data on toxicokinetic and 
metabolism are available. Unfortunately, this 
is frequently not the case for many 
substances relevant for indoor air. Oral to 
inhalative exposure extrapolation is critical, 
and the knowledge is limited. Some aspects 
to be taken into account are summarized by 
Schneider et al. (2003). The authors describe 
that there is a certain likeliehood to 
underestimate the risk. Work is cited which 
showed that the NOAELoral needs to be 
divided by a factor of 1 to 200 to derive a 
correct NOAELinhal.. However, the database 
covering 28 substances was limited. As a 
pragmatic way forward, a one to one 
extrapolation from oral to inhalative 
exposure has been recommended, if there are 
no contradictive data (Technische Regeln 
fuer Gefahrstoffe 901, 2001).   
 
 
SHORT TERM EXPOSURE LEVELS 
INSIDE AUTOMOTIVE VEHICLES 
(STELIA) 
 
Especially at high temperatures some articles 
inside automotive vehicles may emit certain 
VOCs only for a short period of time. As a 
car may be heated up to 65 °C while parking 
in the sun in summertime, relatively high 
concentrations of irritative compounds or 
compounds acting on the central nervous 
system may result. Although the 
concentrations of VOC’s slump down within 
5 minutes after starting to drive, they may 
nevertheless be relevant (Bauhof, 1994). An 
adverse influence on the capability to drive a 
car cannot be excluded, as short term 
exposure to irritating substances may impair 
the vision of the driver, and his attention may 
be depressed by narcotic VOCs. Hence, it 
makes sense to derive Short Term Exposure 
Levels Inside Automotive Vehicles (STELIA) 
for irritating and narcotic properties of 
VOC’s. We recommend a technique 
including three steps: 
 
a. From LOEL to NOEL  
Similarly as described for the derivation of 
ELIAs a factor of three is recommended to 
extrapolate from LOEL (animal) to NOEL 
(animal). Of course this extrapolation is not 
needed if a NOEL for acute exposure is 
already known. As outlined for the derivation 
of ELIAs, the extrapolation from a LOAEL 
to a NOAEL depends on the severeness of 
the effects observed at the LOAEL and the 
slope of the dose-response curve. 
 
b. Interspecies extrapolation 
Usually interspecies differences for acute 
toxic effects are smaller compared to chonic 
toxicity (Hengstler et al., 1998). Therefore, 
we recommend a less complex procedure 
compared to derivation of ELIAs. For 
symptoms of local irritation an extrapolation 
usually is not necessary resulting in a factor 
of one. For other types of acute toxicity a 
factor of 1/3 is recommended. 
 
c. Interindividual differences 
Similar as recommended for ELIAs an intra 
species extrapolation-factor of five is 
recommended. Since the STELIA has been 
constructed to assess short term exposures a 
further factor for exposure-time adjustment, 
such as 1/5 to extrapolate the ELIA, is not 
needed.   
 
Respiratory sensitizers require a specific 
evaluation and are not covered here. The 
problem is a lack of commonly accepted 
animal models for the ranking and 
quantification of the potency of respiratory 
sensitizers.  
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Fig. 2: Strategy to derive a Short Term Exposure Level Inside Automotive Vehicles (STELIA) 
including four steps: a. estimation of the No Observed Effect Level (NOEL) from the Lowest 
Observed Adverse Effect Level (LOAEL), b. extrapolation from laboratory animal to man, c. 
extrapolation to the general population due to interindividual differences.  
 
 
GENOTOXIC SUBSTANCES (ELIA, cm) 
 
It is common understanding that carcinogenic 
and mutagenic substances or substances toxic 
to reproduction of category 1 and 2 must not 
be used as additives for products intended for 
consumer use. However, such substances 
may be present as impurities or degradation 
products. The latter substances are 
considered as a severe problem if they are 
carcinogens without a known threshold 
mechanism (Streffer et al., 2004; Hengstler et 
al., 2003a; Arand et al., 2003). In this case 
large efforts are justified to avoid exposure to 
these carcinogens. For carcinogens that act 
by a threshold mechanism the situation is 
different. In some cases a total ban may be 
not necessary. Therefore, there is a need for 
ELIAs for Carcinogenic and Mutagenic 
Substances, ELIA(cm) acting by threshold 
mechanisms. Substances toxic to 
reproduction act either via non-genotoxic or 
genotoxic mechanisms. In the first case they 
are sufficiently covered by the ELIA 
(chronic), respecting available data on 
toxicity to reproduction. In the second case, 
the ELIA(cm) can be applied, if a threshold 
mechanism is known. We recommend a 
procedure including  two steps: 
 
a. Interspecies extrapolation 
BMD05, the lower 95 % confidence limit for 
the most sensitive tumor type observed in 
laboratory animals, may be used to derive an 
ELIA(cm).  For interspecies extrapolation a 
similar technique as described for the ELIA 
(chronic) may be used.  
 
b. Extrapolation from BMD05 (man) to 
ELIA(cm) 
Derivation of “acceptable” exposures to 
carcinogens is always problematic, even if 
threshold mechanisms have been 
demonstrated. Therefore, our presentation of 
a specific technique should be considered as 
contribution to a controversial discussion 
(Hengstler et al., 2003a; Streffer et al., 2004).  
Nevertheless, we believe that it is better to 
recommend a specific technique also for this 
problematic type of extrapolation. It should 
be considered that the present concept does 
not substitute for a scientific evaluation of 
individual carcinogens. However, our 
concept may help to identify problematic 
exposures that require further evaluation. 
 
Establishment of an ELIA(cm) may be 
facilitated by physiologically based 
pharmacokinetic models (PBPK). In the case 
of vinyl acetate a PBPK model has been 
suggested to derive a threshold exposure 
(Figure 4; Hengstler et al., 2003a). There will 
be no carcinogenic effects if individuals are 
exposed to concentrations below this 
threshold level. It may be discussed 
controversially, whether the data are 
sufficient to justify the proposed threshold of 
50 ppm vinyl acetate (Fig. 4), but the 
demonstrated general principle to define 
thresholds for substances that require toxicity  
for carcinogenic action should be acceptable.
 
Fig. 3: Strategy to derive an Exposure Level Inside Automotive Vehicles (ELIA, cm) for 
carcinogens acting by a threshold mechanism. The suggested technique includes two steps:  
a. interspecies extrapolation to the human BMD05, b. estimation of the ELIA, cm, using an 
uncertainty factor or by specific research that demonstrates threshold doses.  
 
 
The situation is even the more problematic if 
mechanistic studies have shown the existence 
of threshold mechanisms, but no data are 
available defining the level of the threshold 
in human tissues. In this case we recommend 
a conservative procedure, introducing a 
factor of 1/50 000 to extrapolate from the 
BMD05 to ELIA(cm). The idea behind this 
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factor of 1/50 000 is that even under the very 
unlikely most pessimistic assumptions that (i) 
the threshold for carcinogenicity is below the 
ELIA(cm) and (ii) the dose-response curve 
for carcinogenicity is linear the additional 
risk over lifetime exposure is smaller than 
one in a million of exposed individuals 
(Diehl, 2003). This pessimistic assumption 
will usually result in ELIAs(cm) that are 
smaller than the threshold of a substance. We 
suggest application of this conservative 
procedure unless research allows a more 
precise definition of thresholds. If a BMDB05 B 
is not available the ELIA(cm) may also be 
based on the T25-concept. In this case a 
scaling factor has to be applied to extrapolate 
from animal to man, and a divisor of 250 000 
is needed to come down to a lifetime risk of 
smaller than one in a million of exposed 
individuals.  
 
 
PROBLEM OF SYNERGISM 
 
Articles used inside cars usually emit many 
different VOCs. This fact leads to the 
question whether these substances may act 
synergistic, additive or antagonistic. The 
question of interference between different 
toxicants is a fundamental one in toxicology 
(Jung et al., 2003; Hengstler et al., 2002; 
2003a,b; von Mach et al., 2002). For trace 
compounds below their individual threshold 
of action it is generally accepted that their 
action is additive. As an example, see the 
Technical Rules for Handling Dangerous 
Substances No. 403 in Germany (Technische 
Regeln fuer Gefahrstoffe 403, 1989), or the 
concept of “Lowest Concentration of Interest 
(LCI)” for VOC-emissions of construction 
products (AgBB, 2002). In this concept, a 
limit for total VOC of 1 – 3 mg/m³ is set to 
address possible synergistic effects of indoor 
air contaminants. It is recommended to make 
use of this approach also for the evaluation of 
the air quality inside cars. That means, 
 
Σ(CBi B/ELIABi B) ≤ 1,   (1) 
 
and 
 
TVOC ≤ 3 mg/m³ (TVOC: total VOC),  
 
where ELIABi B and CBi B are the exposure limits 
in automotive vehicles respectively the 
concentrations of individual VOCs. This 
approach may be refined. For example, it 
does not make sense to add ELIAs of two 
well investigated substances where one 
substance shows exclusively local irritation 
at mucous membranes and the other 
substance shows exclusively effects to the 
liver. To derive ELIAs specific for the 
different target organs is a cumbersome task 
but is likely of higher toxicological 
relevance. That is,  
 
Σ(CBi B/ELIABi,jB) ≤ 1,  
 
where ELIABi,j B is the ELIA of compound i 
against target organ j. At least local effects 
could be split from systemic effects, so the 
requirements would be  
 
Σ(CBi B/ELIABi, local B) ≤ 1,   (2) 
 
and 
 
Σ(CBi B/ELIABi, systemicB) ≤ 1.  (3) 
 
 
PROBLEM OF LACKING DATA 
 
Several VOCs have only a limited 
toxicological database. This problem was 
also addressed in the concept of Lowest 
Concentration of Interest (LCI) for VOC-
emissions from construction products (AgBB 
2002). VOCs with limited data are compared 
to other compounds with the same functional 
groups. For example, if an aliphatic aldehyde 
is detected and no toxicological data are 
available it is assumed that the LCI of this 
aldehyde is the same as the lowest known 
LCI of an aliphatic aldehyde. As a pragmatic 
approach, it is recommended to proceed with 
ELIAs accordingly.  
 
 
Fig. 4: Demonstration of a threshold mechanism for vinyl acetate in rats.  Panel 1: Predicted 
steady state concentration of acetaldehyde at the basal cells, the progenitor cells of nasal 
cancer, in relation to in vitro doses that produce sister chromatide exchanges. Panel 2: 
Predicted pHi changes in olfactory epithelium of the rat in relation to changes in pHi that are 
cytotoxic to neuronal cells in vitro. pHi reduction is proposed to be the critical step leading to 
cytotoxicity. Panel 3: Olfactory degeneration in rats as a cytotoxic endpoint. Basal cell 
proliferation and the incidence of nasal tumors in rats is presented in panels 4 and 5. 
Olfactory degeneration (cytotoxicity) is observed at 200 ppm. Because acetaldehyde levels 
are only slightly above thresholds, there is no significant tumor response. At 600 ppm all 
thresholds are exceeded, cell proliferation is significantly enhanced and a significant 
incidence of nasal tumors is observed (from: Hengstler et al., 2003a). 
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